Eye health issues that are making the news - Autumn 2022.
Caffeine metabolite may slow child myopia progression in children
Short-sightedness was observed to progress more slowly in children taking a compound derived from coffee, according to a new study.
Researchers found that taking 7-methylxanthine (7-MX) – a caffeine metabolite licensed as a myopia treatment in Denmark since 2009 – was associated with smaller increases in axial elongation and refractive error.
Sign in to continue
Not already a member of the College?
Start enjoying the benefits of College membership today. Take a look at what the College can offer you and view our membership categories and rates.
From national policy influence, historic celebrations and new beginnings, July to September delivered impactful milestones shaping the future of eye care.